All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CIT-013 dosePhase 22 trials

    Citryll BV · Hidradenitis Suppurativa (HS), Rheumatoid Arthritis

  • CNMAu8gold nanocrystalsPhase 22 trials

    Clene Nanomedicine · Amyotrophic Lateral Sclerosis, Multiple Sclerosis

  • COH04S1GEO-CM04S1, Synthetic MVA-based SARS-CoV-2 Vaccine GEO-CM04S1Phase 22 trials

    GeoVax, Inc. · COVID-19 Infection, Hematopoietic and Lymphoid System Neoplasm, Leukemia

  • CRC01Phase 22 trials

    Curocell Inc. · Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL)

  • CRD-4730Phase 22 trials

    Cardurion Pharmaceuticals, Inc. · Catecholaminergic Polymorphic Ventricular Tachycardia, Heart Failure With Reduced Ejection Fraction (HFrEF)

  • CS-1103Phase 22 trials

    Clear Scientific, Inc. · Methamphetamine Intoxication, Methamphetamine Disorders, Methamphetamine Abuse

  • CT1812Study Drug ActivePhase 22 trials

    Cognition Therapeutics · Early Alzheimer's Disease, Dementia With Lewy Bodies

  • CusatuzumabOV-1001, JNJ-74494550Phase 22 trials

    OncoVerity, Inc. · Leukemia, Myeloid, Acute

  • CVL006Phase 22 trials

    Convalife (Shanghai) Co., Ltd. · Advanced Solid Tumor

  • CVL237Phase 22 trials

    Convalife (Shanghai) Co., Ltd. · Advanced Solid Tumors, Locally Advanced or Metastatic Solid Tumors, PTEN Loss or Low Expression

  • CVM-1118TRX-818Phase 22 trials

    TaiRx, Inc. · Hepatocellular Carcinoma, Advanced Cancer, Neuroendocrine Tumors

  • CVXGACVXGA50, PIV5-SARS CoV-2Phase 22 trials

    CyanVac LLC · COVID-19

  • CYH33Phase 22 trials

    Haihe Biopharma Co., Ltd. · PIK3CA-Related Overgrowth Spectrum (PROS), PIK3CA-related Vascular Malformations (PRVM), Ovarian Cancer

  • D3S-001Phase 22 trials

    D3 Bio (Wuxi) Co., Ltd · Advanced Solid Tumors With MAPK Pathway Mutations, KRAS P.G12C

  • DactolisibBEZ235, RTB101Phase 22 trials

    Restorbio Inc. · Respiratory Tract Infections, Covid19

  • DanburstotugIMC-001Phase 22 trials

    ImmuneOncia Therapeutics Inc. · TMB-H, Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors, Extranodal NK/T-cell Lymphoma, Nasal Type

  • DB-1305BNT325Phase 22 trials

    DualityBio Inc. · Solid Tumors, Advanced Solid Tumor

  • DB-3QPhase 22 trials

    Direct Biologics, LLC · Perianal Fistula Due to Crohn's Disease, Crohn Disease (CD)

  • DelamanidPhase 22 trials

    WestVac Biopharma Co., Ltd. · Tuberculosis, Multidrug Resistant Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis

  • DenikitugGS-1811, DENPhase 22 trials

    Gilead Sciences · Advanced Microsatellite Stable Colorectal Cancer, HER2-negative, Gastroesophageal Junction

  • DFV890Phase 22 trials

    Novartis · Coronary Heart Disease, Symptomatic Knee Osteoarthritis

  • DibotatugDR-01Phase 22 trials

    Dren Bio · Bone Marrow Failure Syndromes, Aplastic Anemias, Severe Aplastic Anemia (SAA)

  • DISC-0974Phase 22 trials

    Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia

  • DNA VaccinePhase 22 trials

    NEC Bio B.V · Triple Negative Breast Cancer, Malignant Melanoma, Melanoma (Skin)

  • DNL151BIIB122Phase 22 trials

    Denali Therapeutics Inc. · Parkinson Disease

  • DOC1021Phase 22 trials

    Diakonos Oncology Corporation · Glioblastoma (GBM), Refractory Melanoma

  • Dositinib mesylatePhase 22 trials

    Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer

  • DS-3939aPhase 22 trials

    Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

  • DS-8201Phase 22 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Breast Cancer, Advanced Solid Tumor

  • DS010Phase 22 trials

    Dartsbio Pharmaceuticals Ltd. · Cancer, Cachexia

  • DSP107Phase 22 trials

    Kahr Bio Australia Pty Ltd · Colorectal Cancer, Advanced Solid Tumor, Non Small Cell Lung Cancer

  • DT-101Phase 22 trials

    Draig Therapeutics Ltd · Major Depressive Disorder (MDD)

  • Beijing Biotech · Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Carcinoma

  • DZD6008Phase 22 trials

    Dizal Pharmaceuticals · Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • EB-DART-NK01DLL3, CD56 CAR-NK cellsPhase 22 trials

    Beijing Biotech · Small Cell Lung Cancer (SCLC), Relapsed/Refractory SCLC, Extensive-stage SCLC

  • EB-DNK101 dual-targeting CAR-NK cellsMSLN + MUC1Phase 22 trials

    Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced

  • EB-DNK102 dual-targeting CAR-NK cellsCLDN18.2 + MUC1Phase 22 trials

    Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced

  • EB-DUO-CAR-NK-CEAGCCPhase 22 trials

    Beijing Biotech · Colorectal Cancer Metastatic, Adenocarcinoma of Colon, Colorectal Cancer

  • ECC4703Phase 22 trials

    Eccogene · Adult Obesity, Weight Management, Metabolic Dysfunction-associated Steatohepatitis

  • EDP167Phase 22 trials

    Eddingpharm (Zhuhai) Co., Ltd. · Mixed Dyslipidemia, Homozygous Familial Hypercholesterolemia (HoFH)

  • EfinopegdutideMK-6024, HM12525APhase 22 trials

    Merck & Co. · Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic

  • EG110APhase 22 trials

    Cyllene Therapeutics · Neurogenic Detrusor Overactivity, Spinal Cord Injuries, Urinary Bladder, Overactive

  • EltrekibartLY3041658Phase 22 trials

    Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa

  • EmavusertibCA-4948Phase 22 trials

    Curis, Inc. · Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma

  • ENCell · Sarcopenia, Charcot-Marie-Tooth Disease Type 1A

  • endoxifenPhase 22 trials

    Atossa Therapeutics, Inc. · Precocious Puberty, Gonadotropin-dependent, Breast Neoplasms, Invasive Breast Cancer

  • EnicepatideCT-388, RO7795068Phase 22 trials

    Carmot Therapeutics, Inc. · Obesity, Overweight, Overweight or Obese

  • EnobosarmPhase 22 trials

    Veru Inc. · Obesity & Overweight, Mobility Disability, HOMA-IR

  • ENTR-601-44Phase 22 trials

    Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)

  • ENTR-601-45Phase 22 trials

    Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)

NewerPage 35 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.